The DOI matches its Crossref record; 234 of the 236 references it cites were found in a registry or an index.
p21 in cancer: intricate networks and multiple activities
Open accessAbstract
One of the main engines that drives cellular transformation is the loss of proper control of the mammalian cell cycle. The cyclin-dependent kinase inhibitor p21 (also known as p21WAF1/Cip1) promotes cell cycle arrest in response to many stimuli. It is well positioned to function as both a sensor and an effector of multiple anti-proliferative signals. This Review focuses on recent advances in our understanding of the regulation of p21 and its biological functions with emphasis on its p53-independent tumour suppressor activities and paradoxical tumour-promoting activities, and their implications in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“p21 is a potent cell-cycle inhibitor (39)”
From Txnip Enhances Fitness of Dnmt3a -Mutant Hematopoietic Stem Cells via p21 (2022) · cites this paper as [39]
In the citing paper
“CDKN1A (p21, WAF1, CIP1) was among the first p53 target genes11, 12 to be identified and is now recognized as an encoder for a major cell cycle checkpoint control protein.145”
From Census and evaluation of p53 target genes (2017) · cites this paper as [145]
In the citing paper
“As p21 is rarely genetically affected in cancers [1,124]”
From CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication (2020) · cites this paper as [1]
In the citing paper
“Members of the Krüppel-like factor (KLF) transcription factor (TF) family can activate the CDKN1A gene by cooperating with p300-CREBBP (Aliouat-Denis et al., 2005; Abbas and Dutta, 2009).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Abbas and Dutta, 2009
In the citing paper
“p21WAF1/CIP1 can also be activated by p53 independent mechanisms by other stimulators such as nuclear receptors including androgen, vitamin D and retinoid receptors.”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Abbas and Dutta, 2009
In the citing paper
“Although this is the first detectable event, it is more likely that main role of p21 lies in its capacity to trigger pRb-mediated repression of cell cycle regulators (Fig. 2, for more information on p21 functions (see ref. 98 ).”
From Senescence from G2 arrest, revisited (2015) · cites this paper as [98]
In the citing paper
“For example, cyclin-dependent kinase inhibitor 1A (CDKN1A), a tumor suppressor that is downregulated in multiple cancers (106), is targeted by at least 28 miRNAs and many of which are upregulated together in cancers where CDKN1A has been implicated (107).”
From Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation (2018) · cites this paper as [106]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Cell cycle, CDKs and cancer: a changing paradigm
Malumbres, M., & Barbacid, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2602 · Cited by 3,957 · cited 1×
“CDK1, at least in some tissues, may be the crucial target of p21 in tumorigenesi”
BackgroundRequirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
Tumor spectrum analysis in p53-mutant mice
Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., & Weinberg, R. A. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00002-6 · Cited by 2,051
Xu, X., Yuan, G., Li, Q., Shan, S.-L., & Jiang, S. (2012) · Hepatogastroenterology · doi:10.5754/hge12404 · Cited by 1,825
Restoration of p53 function leads to tumour regression in vivo
Ventura, A., Kirsch, D. G., McLaughlin, M. E., Tuveson, D. A., Grimm, J., Lintault, L., Newman, J., Reczek, E. E., Weissleder, R., & Jacks, T. (2007) · Nature · doi:10.1038/nature05541 · Cited by 1,820 · cited 1×
“Recent work suggests that tumour regression can be achieved through the reactivation of senescence, for example by restoring p53 functio”
BackgroundPCNA, the Maestro of the Replication Fork
Moldovan, G.-L., Pfander, B., & Jentsch, S. (2007) · Cell · doi:10.1016/j.cell.2007.05.003 · Cited by 1,796
Cellular senescence in cancer and aging.
Collado, M., Blasco, M. A., & Serrano, M. (2007) · Cell · doi:10.1016/j.cell.2007.07.003 · Cited by 1,708
Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer
Siegel, P. M., & Massagué, J. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1208 · Cited by 1,626
Role of the INK4a Locus in Tumor Suppression and Cell Mortality
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585
Regulation of the G2/M transition by p53
Taylor, W. R., & Stark, G. R. (2001) · Oncogene · doi:10.1038/sj.onc.1204252 · Cited by 1,584
New functional activities for the p21 family of CDK inhibitors.
LaBaer, J., Garrett, M. D., Stevenson, L. F., Slingerland, J. M., Sandhu, C., Chou, H. S., Fattaey, A., & Harlow, E. (1997) · Genes & Development · doi:10.1101/gad.11.7.847 · Cited by 1,402
Hematopoietic Stem Cell Quiescence Maintained by p21 cip1/waf1
Cheng, T., Rodrigues, N., Shen, H., Yang, Y.-G., Dombkowski, D., Sykes, M., & Scadden, D. T. (2000) · Science · doi:10.1126/science.287.5459.1804 · Cited by 1,339
Radiation-induced cell cycle arrest compromised by p21 deficiency
Brugarolas, J., Chandrasekaran, C., Gordon, J. I., Beach, D., Jacks, T., & Hannon, G. J. (1995) · Nature · doi:10.1038/377552a0 · Cited by 1,242 · cited 1×
“Among these, the small 165 amino acid protein p21 (also known as p21 WAF1/Cip1 ) mediates p53 -dependent G1 growth arres”
BackgroundCDK inhibitors: Cell cycle regulators and beyond
Besson, A., Dowdy, S. F., & Roberts, J. M. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.01.013 · Cited by 1,152
Zhou, B. P., Liao, Y., Xia, W., Spohn, B., Lee, M., & Hung, M. (2001) · Nature Cell Biology · doi:10.1038/35060032 · Cited by 1,148
Sp1 and krüppel‐like factor family of transcription factors in cell growth regulation and cancer
Black, A. R., Black, J. D., & Azizkhan‐Clifford, J. (2001) · Journal of Cellular Physiology · doi:10.1002/jcp.1111 · Cited by 1,048
Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP: tipping the scales of cancer
Frescas, D., & Pagano, M. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2396 · Cited by 903
Multiple Roles of the PI3K/PKB (Akt) Pathway in Cell Cycle Progression
Liang, J., & Slingerland, J. M. (2003) · Cell Cycle · doi:10.4161/cc.2.4.433 · Cited by 885
E2F1-Regulated MicroRNAs Impair TGFβ-Dependent Cell-Cycle Arrest and Apoptosis in Gastric Cancer
Petrocca, F., Visone, R., Onelli, M. R., Shah, M. H., Nicoloso, M. S., Martino, I. D., Iliopoulos, D., Pilozzi, E., Liu, C. G., Negrini, M., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.02.013 · Cited by 832
DNA damage checkpoints: from initiation to recovery or adaptation
Bartek, J., & Lukas, J. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.02.009 · Cited by 784
Transcriptional regulation of the p21((WAF1/CIP1)) gene.
Gartel, A., & Tyner, A. (1999) · Experimental Cell Research · doi:10.1006/excr.1998.4319 · Cited by 735
Niculescu, A. B., Chen, X., Smeets, M. F. M. A., Hengst, L., Prives, C. L., & Reed, S. I. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.629 · Cited by 725
Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation
Khosravi-Far, R., Solski, P. A., Clark, G. J., Kinch, M. S., & Der, C. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.11.6443 · Cited by 683
ASPP Proteins Specifically Stimulate the Apoptotic Function of p53
Samuels-Lev, Y., O'Connor, D. J., Bergamaschi, D., Trigiante, G., Hsieh, J.-K., Zhong, S., Campargue, I., Naumovski, L., Crook, T., & Lu, X. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00367-7 · Cited by 664
Woods, D. B., Parry, D., Cherwinski, H. M., Bosch, E., Lees, E. M., & McMahon, M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5598 · Cited by 639
Rowland, B. D., Bernards, R., & Peeper, D. S. (2005) · Nature Cell Biology · doi:10.1038/ncb1314 · Cited by 593
Requirement for PCNA in DNA Mismatch Repair at a Step Preceding DNA Resynthesis
Umar, A., Buermeyer, A. B., Simon, J. A., Thomas, D. C., Clark, A., Liskay, R. M., & Kunkel, T. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81323-9 · Cited by 577
KLF4, p21 and context-dependent opposing forces in cancer
Rowland, B. D., & Peeper, D. S. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1780 · Cited by 566
Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1
Luo, Y., Hurwitz, J., & Massagué, J. (1995) · Nature · doi:10.1038/375159a0 · Cited by 549
Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA
Chen, J., Jackson, P. K., Kirschner, M. W., & Dutta, A. (1995) · Nature · doi:10.1038/374386a0 · Cited by 548 · cited 1×
“p21-mediatedgrowth inhibition has been attributed to two main activities that depend on two non-overlapping structural domains: the carboxy-terminal PCNA-binding domain and the amino-terminal CDK–cyclin inhibitory domai”
BackgroundSelf-citationA role for Rho in Ras transformation
Qiu, R. G., Chen, J., McCormick, F., & Symons, M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11781 · Cited by 533
Role of the SCFSkp2 Ubiquitin Ligase in the Degradation of p21Cip1 in S Phase
Bornstein, G., Bloom, J., Sitry-Shevah, D., Nakayama, K., Pagano, M., & Hershko, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301774200 · Cited by 508
Dankort, D. L., Filenova, E., Collado, M., Serrano, M., Jones, K. D., & McMahon, M. (2007) · Genes & Development · doi:10.1101/gad.1516407 · Cited by 492
Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis
Sarkisian, C. J., Keister, B. A., Stairs, D. B., Boxer, R. B., Moody, S. E., & Chodosh, L. A. (2007) · Nature Cell Biology · doi:10.1038/ncb1567 · Cited by 490
An Intestine-Specific Homeobox Gene Regulates Proliferation and Differentiation
Suh, E. R., & Traber, P. G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.2.619 · Cited by 487
Proliferation of cancer cells despite CDK2 inhibition
Tetsu, O., & McCormick, F. P. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00053-9 · Cited by 472
p21WAF1/Cip1: more than a break to the cell cycle?
Dotto, G. P. (2000) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(00)00019-6 · Cited by 470
Myc represses transcription through recruitment of DNA methyltransferase corepressor
Brenner, C., Deplus, R., Mirjolet, C., Loriot, A. E., Viré, E. A., Smet, C. D., Gutiérrez, A., Danovi, D., Bernard, D., Boon, T., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600509 · Cited by 468
Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1
Olson, M. F., Paterson, H. F., & Marshall, C. J. (1998) · Nature · doi:10.1038/28425 · Cited by 461
Roninson, I. B. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00847-3 · Cited by 443
Li, Y., Dowbenko, D. J., & Lasky, L. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109062200 · Cited by 442
KLF6 , a Candidate Tumor Suppressor Gene Mutated in Prostate Cancer
Narla, G., Heath, K. E., Reeves, H. L., Li, D., Giono, L. E., Kimmelman, A. C., Glucksman, M., Narla, J., Eng, F. J., Chan, A. M.-L., et al. (2001) · Science · doi:10.1126/science.1066326 · Cited by 442
Kippin, T. E., Martens, D. J., & van der Kooy, D. (2005) · Genes & Development · doi:10.1101/gad.1272305 · Cited by 442
Chang, B.-D., Watanabe, K., Broude, E. V., Fang, J., Poole, J. C., Kalinichenko, T. V., & Roninson, I. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.4291 · Cited by 432
Choudhury, A. R., Ju, Z., Djojosubroto, M. W., Schienke, A., Lechel, A., Schaetzlein, S., Jiang, H., Stepczynska, A., Wang, C., Buer, J., et al. (2007) · Nature Genetics · doi:10.1038/ng1937 · Cited by 426
Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation
Wu, C.-H., van Riggelen, J., Yetil, A., Fan, A. C., Bachireddy, P., & Felsher, D. W. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701953104 · Cited by 417
Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21 CIP1/WAF1 and cyclin D proteins
Yu, Z.-K., Gervais, J., & Zhang, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.19.11324 · Cited by 410
Proteasomal Turnover of p21Cip1 Does Not Require p21Cip1 Ubiquitination
Sheaff, R. J., Singer, J. D., Swanger, J., Smitherman, M., Roberts, J. M., & Clurman, B. E. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80435-9 · Cited by 382
Recruitment of DNA methyltransferase I to DNA repair sites
Mortusewicz, O., Schermelleh, L., Walter, J., Cardoso, M. C., & Leonhardt, H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501034102 · Cited by 380
Rössig, L., Jadidi, A., Urbich, C., Badorff, C., Zeiher, A. M., & Dimmeler, S. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.16.5644-5657.2001 · Cited by 378
Absence of WAF1 mutations in a variety of human malignancies
Shiohara, M., El‐Deiry, W. S., Wada, M., Nakamaki, T., Takeuchi, S., Yang, R., Chen, D., Vogelstein, B., & Koeffler, H. (1994) · Blood · doi:10.1182/blood.v84.11.3781.bloodjournal84113781 · Cited by 366
Abbas, T., Sivaprasad, U., Terai, K., Amador, V., Pagano, M., & Dutta, A. (2008) · Genes & Development · doi:10.1101/gad.1676108 · Cited by 363
Self-citationNuclear Accumulation of p21 Cip1 at the Onset of Mitosis: a Role at the G 2 /M-Phase Transition
Dulić, V., Stein, G. H., Far, D. F., & Reed, S. I. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.546 · Cited by 352
Tumor susceptibility of p21(Waf1/Cip1)-deficient mice.
Martín‐Caballero, J., Flores, J. M., Garcı́a, P., & Serrano, M. (2001) · PubMed · Cited by 352
(1999) · PubMed · Cited by 338
Zhang, W., Geiman, D. E., Shields, J. M., Dang, D. T., Mahatan, C. S., Kaestner, K. H., Biggs, J. R., Kraft, A. S., & Yang, V. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000062200 · Cited by 333
Cyclin-Binding Motifs Are Essential for the Function of p21 CIP1
Chen, J., Saha, P., Kornbluth, S., Dynlacht, B. D., & Dutta, A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4673 · Cited by 320
Self-citationCell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells
Viale, A., Franco, F., Orleth, A., Cambiaghi, V., Giuliani, V., Bossi, D., Ronchini, C., Ronzoni, S., Muradore, I., Monestiroli, S., et al. (2008) · Nature · doi:10.1038/nature07618 · Cited by 314
Missero, C., Cunto, F. D., Kiyokawa, H., Koff, A., & Dotto, G. P. (1996) · Genes & Development · doi:10.1101/gad.10.23.3065 · Cited by 311
Identification of Krüppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer
Zhao, W., Hisamuddin, I. M., Nandan, M. O., Babbin, B. A., Lamb, N. E., & Yang, V. W. (2004) · Oncogene · doi:10.1038/sj.onc.1207067 · Cited by 307
Franklin, D. S., Godfrey, V., O’Brien, D. A., Deng, C., & Xiong, Y. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.16.6147-6158.2000 · Cited by 303
Ubiquitin-Independent Degradation of Cell-Cycle Inhibitors by the REGγ Proteasome
Chen, X., Barton, L. F., Chi, Y., Clurman, B. E., & Roberts, J. M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.022 · Cited by 276
Ubiquitin- and ATP-Independent Proteolytic Turnover of p21 by the REGγ-Proteasome Pathway
Li, X., Amazit, L., Long, W., Lonard, D. M., Monaco, J. J., & O’Malley, B. W. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.028 · Cited by 267
Krüppel-like Factor 4 Mediates p53-dependent G1/S Cell Cycle Arrest in Response to DNA Damage
Yoon, H. S., Chen, X., & Yang, V. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211027200 · Cited by 265
Cooperative effects of genes controlling the G2/M checkpointPreprint
Chan, T. A.-T., Hwang, P. M., Hermeking, H., Kinzler, K. W., & Vogelstein, B. (2000) · Genes & Development · doi:10.1101/gad.14.13.1584 · Cited by 261
p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F.Preprint
Zhu, L., Harlow, E. E., & Dynlacht, B. D. (1995) · Genes & Development · doi:10.1101/gad.9.14.1740 · Cited by 252
Histone deacetylase inhibitors: Signalling towards p21cip1/waf1
Ocker, M., & Schneider‐Stock, R. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.03.001 · Cited by 252
Kim, Y.-S., Ratziu, V., Choi, S.-G., Lalazar, A., Theiss, G., Dang, Q., Kim, S., & Friedman, S. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.50.33750 · Cited by 249
ID genes mediate tumor reinitiation during breast cancer lung metastasis
Gupta, G. P., Perk, J., Acharyya, S., de Candia, P., Mittal, V., Manova-Todorova, K., Gerald, W. L., Brogi, E., Benezra, R., & Massagué, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709185104 · Cited by 245
Nishitani, H., Shiomi, Y., Iida, H., Michishita, M., Takami, T., & Tsurimoto, T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806045200 · Cited by 241
The CRL4Cdt2 ubiquitin ligase targets the degradation of p21Cip1 to control replication licensing
Kim, Y., Starostina, N. G., & Kipreos, E. T. (2008) · Genes & Development · doi:10.1101/gad.1703708 · Cited by 240
Zhang, Y., Fujita, N., & Tsuruo, T. (1999) · Oncogene · doi:10.1038/sj.onc.1202426 · Cited by 238
Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes
Gartel, A. L., & Shchors, K. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00020-4 · Cited by 238
Touitou, R., Richardson, J., Bose, S., Nakanishi, M., Rivett, J., & Allday, M. J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.10.2367 · Cited by 235
p21/CDKN1A Mediates Negative Regulation of Transcription by p53
Löhr, K., Möritz, C., Contente, A., & Dobbelstein, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212517200 · Cited by 227
Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27Kip1 and p21Cip1
Martín, A., Odajima, J., Hunt, S. L., Dubus, P. R., Ortega, S., Malumbres, M., & Barbacid, M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.05.006 · Cited by 223
p21 Inhibits Thr161 Phosphorylation of Cdc2 to Enforce the G2 DNA Damage Checkpoint
Smits, V. A. J., Klompmaker, R., Vallenius, T., Rijksen, G., Mäkelä, T. P., & Medema, R. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005437200 · Cited by 221
Glycogen Synthase Kinase-3 Couples AKT-dependent Signaling to the Regulation of p21Cip1 Degradation
Rössig, L., Badorff, C., Holzmann, Y., Zeiher, A. M., & Dimmeler, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106157200 · Cited by 218
Devgan, V., Mammucari, C., Millar, S. E., Brisken, C., & Dotto, G. P. (2005) · Genes & Development · doi:10.1101/gad.341405 · Cited by 209
APC/CCdc20 Controls the Ubiquitin-Mediated Degradation of p21 in Prometaphase
Amador, V., Ge, S., Santamarı́a, P. G., Guardavaccaro, D., & Pagano, M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.06.013 · Cited by 207
p21Cip1 Promotes Cyclin D1 Nuclear Accumulation via Direct Inhibition of Nuclear Export
Alt, J. R., Gladden, A. B., & Diehl, J. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108867200 · Cited by 199
Topley, G., Okuyama, R., Gonzales, J. G., Conti, C. J., & Dotto, G. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9089 · Cited by 197
Notch1 modulates timing of G1-S progression by inducing SKP2 transcription and p27Kip1 degradation
Sarmento, L. M., Huang, H., Limón, A., Gordon, W., Fernandes, J., Tavares, M. J., Miele, L., Cardoso, A. A., Classon, M., & Carlesso, N. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050559 · Cited by 191
The Cdx-1 and Cdx-2 homeobox genes in the intestine
Freund, J., Domon–Dell, C., Kédinger, M., & Duluc, I. (1998) · Biochemistry and Cell Biology · doi:10.1139/o99-001 · Cited by 189
Child, E. S., & Mann, D. J. (2006) · Cell Cycle · doi:10.4161/cc.5.12.2863 · Cited by 185
Murphy, G. P., Tjoa, B. A., Simmons, S. J., Ragde, H., Rogers, M., Elgamal, A., Kenny, G. M., Troychak, M. J., Salgaller, M. L., & Boynton, A. L. (1999) · The Prostate · doi:10.1002/(sici)1097-0045(19990401)39:1 · Cited by 185
Kruppel-like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer☆
Reeves, H. L., Narla, G., Ogunbiyi, O. A., Haq, A., Katz, A. M., Benzeno, S., Hod, E. A., Harpaz, N., Goldberg, S., & Kremer-Tal, S. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.005 · Cited by 184
Cell cycle arrest and DNA endoreduplication following p21Waf1/Cip1 expression
Bates, S., Ryan, K. M., Phillips, A. C., & Vousden, K. H. (1998) · Oncogene · doi:10.1038/sj.onc.1202104 · Cited by 176
p53 Down-Regulates CHK1 through p21 and the Retinoblastoma Protein
Gottifredi, V., Karni-Schmidt, O., Shieh, S.-Y., & Prives, C. L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.4.1066-1076.2001 · Cited by 174
Yasui, K., Arii, S., Zhao, C. N., Imoto, I., Ueda, M., Nagai, H., Emi, M., & Inazawa, J. (2002) · Hepatology · doi:10.1053/jhep.2002.33683 · Cited by 171
Sassano, A., & Platanias, L. C. (2008) · Cancer Letters · doi:10.1016/j.canlet.2007.11.036 · Cited by 171
Wang, Y., Elson, A., & Leder, P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14590 · Cited by 170
Coqueret, O., & Gascan, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001601200 · Cited by 169
Xia, W., Chen, J., Zhou, X. C., Sun, P.-R., Lee, D., Liao, Y., Zhou, B. P., & Hung, M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0527 · Cited by 167
Ms, S., Rochefort, H., & Garcia, M. (1995) · PubMed · Cited by 162
Barnouin, K., Dubuisson, M., Child, E. S., de Mattos, S. F., Glassford, J., Medema, R. H., Mann, D. J., & Lam, E. W. ‐. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111123200 · Cited by 161
Medema, R. H., Klompmaker, R., Smits, V. A., & Rijksen, G. (1998) · Oncogene · doi:10.1038/sj.onc.1201558 · Cited by 161
Cell cycle checkpoints and their impact on anticancer therapeutic strategies
Eastman, A. R. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10699 · Cited by 161
Liu, S., Bishop, W. R., & Liu, M. (2003) · Drug Resistance Updates · doi:10.1016/s1368-7646(03)00044-x · Cited by 160
Chen, L.-C., Manjeshwar, S., Lu, Y., Moore, D. H., Ljung, B., Kuo, W., Dairkee, S. H., Wernick, M., Collins, C. C., & Smith, H. S. (1998) · PubMed · Cited by 157
Cdx-2 homeodomain protein expression in human and rat colorectal adenoma and carcinoma.
Ee, H. C., Erler, T., Bhathal, P. S., Young, G. P., & James, R. J. (1995) · Europe PMC (PubMed Central) · Cited by 155
p21 Is a Critical CDK2 Regulator Essential for Proliferation Control in Rb-deficient Cells
Brugarolas, J., Bronson, R. T., & Jacks, T. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.2.503 · Cited by 153
AP4 encodes a c-MYC-inducible repressor of p21
Jung, P., Menssen, A., Mayr, D. C., & Hermeking, H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801773105 · Cited by 153
Increased levels of p21WAF1/Cip1 in human brain tumors.
Jung, J., Bruner, J. M., Ruan, S., Langford, L. A., Kyritsis, A. P., Kobayashi, Y., Levin, V. A., & Zhang, W. (1995) · PubMed · Cited by 153
Biankin, A. V., Kench, J. G., Morey, A. L., Lee, C. S. L., Biankin, S. A., Head, D. R., Hugh, T. B., Henshall, S. M., & Sutherland, R. L. (2001) · PubMed · Cited by 148
Regulation of p21WAF1/CIP1 Stability by WISp39, a Hsp90 Binding TPR Protein
Jascur, T., Brickner, H., Salles-Passador, I., Barbier, V., El Khissiin, A., Smith, B., Fotedar, R., & Fotedar, A. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.11.049 · Cited by 145
Yang, W., Mathew, J., Velcich, A., Edelmann, W., Kucherlapati, R., Lipkin, M., Yang, K., & Augenlicht, L. H. (2001) · PubMed · Cited by 145
Cytosine Methylation and DNA Repair
Walsh, C. P., & Xu, G. L. (2006) · Springer eBooks · doi:10.1007/3-540-31390-7_11 · Cited by 143
Control of E2F activity by p21Waf1/Cip1
Delavaine, L., & Thangue, N. B. L. (1999) · Oncogene · doi:10.1038/sj.onc.1202923 · Cited by 143
Caffo, O., Doglioni, C., Veronese, S. M., Bonzanini, M., Marchetti, A., Buttitta, F., Fina, P., Leek, R., Morelli, L., Palma, P., et al. (1996) · PubMed · Cited by 142
Kremer-Tal, S., Reeves, H. L., Narla, G., Thung, S. N., Schwartz, M., DiFeo, A. V., Katz, A. M., Bruix, J., Bioulac‐Sage, P., Martignetti, J. A., et al. (2004) · Hepatology · doi:10.1002/hep.20460 · Cited by 141
Overexpression of Id‐1 is associated with poor clinical outcome in node negative breast cancer
SCHOPPMANN, S. F., Schindl, M., Bayer, G., Aumayr, K., Dienes, J., Horvat, R., Rudas, M., Gnant, M., Jakesz, R., & Birner, P. (2003) · International Journal of Cancer · doi:10.1002/ijc.11009 · Cited by 139
Serological evidence of an association betweenChlamydia pneumoniae infection and lung cancer
Laurila, A. L., Anttila, T., Läärä, E., Bloigu, A. H., Virtamo, J., Albanes, D., Leinonen, M., & Saikku, P. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970220)74:1 · Cited by 138
Deletion, Mutation, and Loss of Expression of KLF6 in Human Prostate Cancer
Chen, C., Hyytinen, E., Sun, X., Helin, H. J., Koivisto, P. A., Frierson, H. F., Vessella, R. L., & Dong, J. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63930-2 · Cited by 137
Ito, G., Uchiyama, M., Kondo, M., Mori, S., Usami, N., Maeda, O., Kawabe, T., Hasegawa, Y., Shimokata, K., & Sekido, Y. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0185 · Cited by 136
Schindl, M., SCHOPPMANN, S. F., Ströbel, T., Heinzl, H., Leisser, C., Horvat, R., & Birner, P. (2003) · PubMed · Cited by 136
Over Expression of ID-1 in Prostate Cancer
Ouyang, X., Wang, X., LEE, D. T. W., Tsao, S. W., & Wong, Y. C. (2002) · The Journal of Urology · doi:10.1016/s0022-5347(05)65044-6 · Cited by 135
Kitaura, H., Shinshi, M., Uchikoshi, Y., Ono, T., Tsurimoto, T., Yoshikawa, H., Iguchi‐Ariga, S. M. M., & Ariga, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10477 · Cited by 135
p53-dependent Down-regulation of Telomerase Is Mediated by p21
Shats, I., Milyavsky, M., Tang, X., Stambolsky, P., Erez, N., Brosh, R., Kogan, I., Braunstein, I., Tzukerman, M., Ginsberg, D., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402502200 · Cited by 133
A Novel Transcriptional Repression Domain Mediates p21WAF1/CIP1 Induction of p300 Transactivation
Snowden, A. W., Anderson, L. A., Webster, G., & Perkins, N. D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.8.2676-2686.2000 · Cited by 126
Protein expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas
Bukholm, I. K., & Nesland, J. M. (2000) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280050034 · Cited by 126
Hiyama, H., Iavarone, A., & Reeves, S. A. (1998) · Oncogene · doi:10.1038/sj.onc.1201667 · Cited by 125
CDX2 is mutated in a colorectal cancer with normal APC/β-catenin signaling
da Costa, L. T., He, T., Yu, J., Sparks, A. B., Morin, P. J., Polyák, K., Laken, S., Vogelstein, B., & Kinzler, K. W. (1999) · Oncogene · doi:10.1038/sj.onc.1202872 · Cited by 125
Takubo, K., Ohmura, M., Azuma, M., Nagamatsu, G., Yamada, W., Arai, F., Hirao, A., & Suda, T. (2008) · Cell stem cell · doi:10.1016/j.stem.2007.10.023 · Cited by 122
Mandal, M., Bandyopadhyay, D., Goepfert, T. M., & Kumar, R. (1998) · Oncogene · doi:10.1038/sj.onc.1201529 · Cited by 122
Dang, D. T., Mahatan, C. S., Dang, L. H., Agboola, I. A., & Yang, V. W. (2001) · Oncogene · doi:10.1038/sj.onc.1204645 · Cited by 120
伊藤, 源. (2005) · 名古屋大学 eBooks · Cited by 119
Mukherjee, S., & Conrad, S. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502278200 · Cited by 117
Early alteration of cell-cycle-regulated gene expression in colorectal neoplasia.
Polyák, K., Hamilton, S. R., Vogelstein, B., & Kinzler, K. W. (1996) · Europe PMC (PubMed Central) · Cited by 116
The conflicting roles of the cdk inhibitor p21(CIP1/WAF1) in apoptosis
Gartel, A. L. (2005) · Leukemia Research · doi:10.1016/j.leukres.2005.04.023 · Cited by 116
Swarbrick, A., Roy, E., Allen, T., & Bishop, J. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801505105 · Cited by 111
p21 delays tumor onset by preservation of chromosomal stability
Barboza, J., Liu, G., Ju, Z., El‐Naggar, A. K., & Lozano, G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606343104 · Cited by 110
Subcellular localisation of cyclin B, Cdc2 and p21WAF1/CIP1 in breast cancer
Winters, Z., Hunt, N., Bradburn, M. J., Royds, J. A., Turley, H., Harris, A. L., & Norbury, C. J. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00327-6 · Cited by 110
p21CIP1 and Cdc25A: Competition between an Inhibitor and an Activator of Cyclin-Dependent Kinases
Saha, P., Eichbaum, Q. G., Silberman, E. D., Mayer, B. J., & Dutta, A. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.8.4338 · Cited by 108
Self-citationWinters, Z., Leek, R., Bradburn, M. J., Norbury, C. J., & Harris, A. L. (2003) · Breast Cancer Research · doi:10.1186/bcr654 · Cited by 106
Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest.
Park, M., Chae, H.-D., Yun, J., Jung, M., Kim, Y. S., Kim, S., Han, M. H., & Shin, D. Y. (2000) · PubMed · Cited by 105
Mantel, C., Luo, Z., Canfield, J., Braun, S. E., Deng, C., & Broxmeyer, H. (1996) · Blood · doi:10.1182/blood.v88.10.3710.bloodjournal88103710 · Cited by 102
P21Cip1/WAF1 downregulation is required for efficient PCNA ubiquitination after UV irradiation
Soria, G., Podhajcer, O. L., Prives, C. L., & Gottifredi, V. (2005) · Oncogene · doi:10.1038/sj.onc.1209315 · Cited by 100
Minucci, S., Monestiroli, S., Giavara, S., Ronzoni, S., Marchesi, F., Insinga, A., Diverio, D., Gasparini, P., Capillo, M., Colombo, E., et al. (2002) · Blood · doi:10.1182/blood-2001-11-0089 · Cited by 100
Interstitial fluid pressure in cervical carcinoma
Milosevic, M., Fyles, A., Wong, R. K. W., Pintilie, M., Kavanagh, M.-C., Levin, W., Manchul, L., Keane, T. J., & Hill, R. P. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980615)82:12 · Cited by 100
Redox Activation of p21 Cip1/WAF1/Sdi1 : A Multifunctional Regulator of Cell Survival and Death
O’Reilly, M. A. (2004) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.108 · Cited by 98
CDX2, a homeobox transcription factor, upregulates transcription of the p21/WAF1/CIP1 gene
Bai, Y.-Q., Miyaké, S., Iwai, T., & Yuasa, Y. (2003) · Oncogene · doi:10.1038/sj.onc.1206634 · Cited by 98
Tumor suppression by p27Kip1 and p21Cip1 during chemically induced skin carcinogenesis
Philipp, J., Vo, K., Gurley, K. E., Seidel, K. D., & Kemp, C. J. (1999) · Oncogene · doi:10.1038/sj.onc.1202840 · Cited by 98
The role of human papillomavirus oncoproteins E6 and E7 in apoptosis
Finzer, P., Aguilar‐Lemarroy, A., & Rösl, F. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00431-7 · Cited by 96
p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer
Anttila, M., Kosma, V.-M., Hongxiu, J., Puolakka, J. O., Juhola, M., Saarikoski, S., & Syrjänen, K. J. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690298 · Cited by 94
Soria, G., Speroni, J., Podhajcer, O. L., Prives, C., & Gottifredi, V. (2008) · Journal of Cell Science · doi:10.1242/jcs.027730 · Cited by 94
Zhang, W., Kornblau, S. M., Kobayashi, T., Gambel, A. M., Claxton, D. F., & Deisseroth, A. B. (1995) · PubMed · Cited by 93
Genetic instability in cancer cells by impaired cell cycle checkpoints
Nakanishi, M., Shimada, M., & Niida, H. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00289.x · Cited by 93
Ueki, T., Nishidate, T., Park, J. H., Lin, M., Shimo, A., Hirata, K., Nakamura, Y., & Katagiri, T. (2008) · Oncogene · doi:10.1038/onc.2008.186 · Cited by 91
Loss of p21WAF1/CIP1 accelerates Ras oncogenesis in a transgenic/knockout mammary cancer model
Adnane, J., Jackson, R. J., Nicosia, S. V., Cantor, A. B., Pledger, W. J., & Sebti, S. M. (2000) · Oncogene · doi:10.1038/sj.onc.1203956 · Cited by 91
Tumor suppressor functions for the Cdk inhibitor p21 in the mouse colon
Poole, A. J., Heap, D., Carroll, R. E., & Tyner, A. L. (2004) · Oncogene · doi:10.1038/sj.onc.1207994 · Cited by 90
p21 expression as a predictor for favorable prognosis in squamous cell carcinoma of the lung.
Komiya, T., Hosono, Y., Hirashima, T., Masuda, N., Yasumitsu, T., Nakagawa, K., Kikui, M., Ohno, A., Fukuoka, M., & Kawase, I. (1997) · PubMed · Cited by 89
Transforming growth factor-? responsiveness inDPC4/SMAD4-null cancer cells
Dai, J. L., Schutte, M. E. M., Bansal, R. K., Wilentz, R. E., Sugar, A. Y., & Kern, S. E. (1999) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199909)26:1 · Cited by 88
Role of p21WAF1 in the Cellular Response to UV
Fotedar, R., Bendjennat, M., & Fotedar, A. (2004) · Cell Cycle · doi:10.4161/cc.3.2.658 · Cited by 86
Bae, D., Cho, S. B., Kim, Y., Whang, J.-D., Song, S.-Y., Park, C.-S., Kim, D. S., & Lee, J. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2001.6196 · Cited by 85
Baretton, G. B., Klenk, U., Diebold, J., Schmeller, N. T., & Löhrs, U. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690390 · Cited by 84
Pan, H., Chou, H.-Y. E., Liu, S.-H., Peng, S., Liu, C.-L., & Hsu, H. (2006) · Cell Cycle · doi:10.4161/cc.5.22.3500 · Cited by 84
Ukomadu, C., & Dutta, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307194200 · Cited by 84
Self-citationp21 Disrupts the Interaction between cdk2 and the E2F-p130 Complex
Shiyanov, P. A., Bagchi, S., Adami, G. R., Kokontis, J. M., Hay, N., Arroyo, M., Morozov, A., & Raychaudhuri, P. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.737 · Cited by 83
Edmonston, T. B. (2000) · Human Pathology · doi:10.1053/hupa.2000.20383 · Cited by 83
Yun, J., Chae, H.-D., Choi, T., Kim, E. H., Bang, Y., Chung, J., Choi, K. S., Mantovani, R., & Shin, D. Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305178200 · Cited by 82
ATM and p21 Cooperate to Suppress Aneuploidy and Subsequent Tumor Development
Shen, K. C., Heng, H. H., Wang, Y., Lu, S., Liu, G., Deng, C., Brooks, S. C., & Wang, Y. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1471 · Cited by 82
Hafkamp, H. C., Mooren, J. J., Claessen, S. M. H., Klingenberg, B., Voogd, A. C., Bot, F., Klußmann, J. P., Hopman, A. H. N., Manni, J. J., Kremer, B., et al. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.23 · Cited by 81
Hwang‐Verslues, W. W., & Sladek, F. M. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0298 · Cited by 81
Jackson, R. J., Adnane, J., Coppola, D., Cantor, A. B., Sebti, S. M., & Pledger, W. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205946 · Cited by 77
Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma
de la Cueva, E., Garcı́a-Cao, I., Herranz, M., López, P., Garcı́a, P., Flores, J. M., Serrano, M., Fernández‐Piqueras, J., & Martín‐Caballero, J. (2006) · Oncogene · doi:10.1038/sj.onc.1209432 · Cited by 77
Lü, X., Toki, T., Konishi, I., Nikaido, T., & Fujii, S. (1998) · PubMed · Cited by 76
Ubiquitination of p21Cip1/WAF1 by SCFSkp2: Substrate Requirement and Ubiquitination Site Selection
Wang, W., Nacusi, L. P., Sheaff, R. J., & Liu, X. (2005) · Biochemistry · doi:10.1021/bi051071j · Cited by 75
p21WAF1/CIP1 Selectively Controls the Transcriptional Activity of Estrogen Receptor α
Fritah, A., Saucier, C., Mešter, J., Redeuilh, G., & Sabbah, M. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.6.2419-2430.2005 · Cited by 75
Activation and repression of p21WAF1/CIP1 transcription by RB binding proteins
Gartel, A. L., Goufman, E., Tevosian, S. G., Shih, H. H., Yee, A. S., & Tyner, A. L. (1998) · Oncogene · doi:10.1038/sj.onc.1202240 · Cited by 74
Gartel, A. L. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0163 · Cited by 74
Xu, C., Meikrantz, W., Schlegel, R., & Sager, R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7829 · Cited by 72
Ogino, S., Kawasaki, T., Kirkner, G. J., Ogawa, A., Dorfman, I., Loda, M. F., & Cs, F. (2006) · The Journal of Pathology · doi:10.1002/path.2030 · Cited by 71
Gong, J., Ammanamanchi, S., Ko, T. C., & Brattain, M. G. (2003) · PubMed · Cited by 69
PDK1‐dependent activation of atypical PKC leads to degradation of the p21 tumour modifier protein
Scott, M. T., Ingram, A., & Ball, K. L. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf684 · Cited by 69
Tumorigenic effect of nonfunctional p53 or p21 in mice mutant in the Werner syndrome helicase.
Lebel, M., Cardiff, R. D., & Leder, P. (2001) · PubMed · Cited by 68
Regulatory Roles of p21 and Apurinic/Apyrimidinic Endonuclease 1 in Base Excision Repair
Tom, S., Ranalli, T. A., Podust, V. N., & Bambara, R. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m109626200 · Cited by 65
p53, p21 and p27 protein expression in head and neck cancer and their prognostic value.
Kapranos, N., Stathopoulos, G. P., Manolopoulos, L., Kokka, E., Papadimitriou, C., Bibas, A. G., Yiotakis, J., & Adamopoulos, G. K. (2001) · PubMed · Cited by 64
Weinberg, W. C., Fernández‐Salas, E., Morgan, D. L., Shalizi, A., Mirosh, E., Stanulis, E., Deng, C., Hennings, H., & Yuspa, S. H. (1999) · PubMed · Cited by 64
Differential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties.
Bearss, D. J., Lee, R. J., Troyer, D. A., Pestell, R. G., & Windle, J. J. (2002) · PubMed · Cited by 62
Bahl, R., Arora, S., Nath, N., Mathur, M., Shukla, N. K., & Ralhan, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203325 · Cited by 62
The p21Waf1 pathway is involved in blocking leukemogenesis by the t(8;21) fusion protein AML1-ETO
Peterson, L. F., Yan, M., & Zhang, D. (2007) · Blood · doi:10.1182/blood-2006-03-012575 · Cited by 61
Beck, S. E., Jung, B. H., Rosario, E. D., Gómez, J., & Carethers, J. M. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.01.017 · Cited by 61
Regulation of Kruppel-like Factor 6 Tumor Suppressor Activity by Acetylation
Li, D., Yea, S., Dolios, G., Martignetti, J. A., Narla, G., Wang, R., Walsh, M. J., & Friedman, S. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1040 · Cited by 59
Stoyanova, T. I., Yoon, T., Kopanja, D., MOKYR, M. B., & Raychaudhuri, P. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00880-07 · Cited by 57
Inactivation of p21 Enhances Intestinal Tumor Formation in Muc2−/− Mice
Yang, W., Velcich, A., Lozonschi, I., Liang, J., Nicholas, C., Zhuang, M., Bancroft, L. K., & Augenlicht, L. H. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62342-5 · Cited by 57
Functional Analysis of a p21 Mutant (Arg94→ Trp) Identified in a Human Breast Carcinoma
Balbı́n, M., Hannon, G. J., Pendás, A. M., Ferrando, A. A., Vizoso, F. J., Fueyo, A., & López-Otı́n, C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.26.15782 · Cited by 55
Aberrant expression of p21WAF1/CIP1 and p27KIP1 in cervical carcinoma
Cheung, T. H., Lo, K. W. K., Yu, M. M. Y., Yim, S. F., Poon, C. S., Chung, T. K. H., & Wong, Y. F. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00624-3 · Cited by 54
p21WAF1/CIP1 protein expression in primary ovarian cancer.
Ferrandina, G., Stoler, A., Fagotti, A., Fanfani, F., Sacco, R., Pasqua, A. D., Mancuso, S., & Scambia, G. (2000) · International Journal of Oncology · doi:10.3892/ijo.17.6.1231 · Cited by 54
The role of cyclin D2 and p21/waf1 in human T-cell leukemia virus type 1 infected cells
Kehn‐Hall, K., Deng, L., de la Fuente, C., Strouss, K. M., Wu, K., Maddukuri, A., Baylor, S., Rufner, R., Pumfery, A. M., Bottazzi, M. E., et al. (2004) · Retrovirology · doi:10.1186/1742-4690-1-6 · Cited by 54
Somatic cell type specific gene transfer reveals a tumor‐promoting function for p21Waf1/Cip1
Liu, Y., Yeh, N., Zhu, X.-H., Leversha, M. A., Cordon‐Cardo, C., Ghossein, R. A., Singh, B., Holland, E. C., & Koff, A. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601886 · Cited by 52
Forootan, S. S., Wong, Y. C., Dodson, A. R., Wang, X., Lin, K., Smith, P. H., Foster, C. S., & Ke, Y. (2007) · Human Pathology · doi:10.1016/j.humpath.2007.02.011 · Cited by 51
A role for E2F1 in Ras activation of p21(WAF1/CIP1) transcription
Gartel, A. L., Najmabadi, F., Goufman, E., & Tyner, A. L. (2000) · Oncogene · doi:10.1038/sj.onc.1203411 · Cited by 50
Järviluoma, A., Child, E. S., Sarek, G., Sirimongkolkasem, P., Peters, G. G., Ojala, P. M., & Mann, D. J. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.6.2430-2440.2006 · Cited by 49
Ralhan, R., Agarwal, S., Mathur, M., Wasylyk, B., & Srivastava, A. (2000) · PubMed · Cited by 47
Wagayama, H., Shiraki, K., Sugimoto, K., Ito, T., Fujikawa, K., Yamanaka, T., Takase, K., & Nakano, T. (2002) · Human Pathology · doi:10.1053/hupa.2002.124724 · Cited by 46
Korkolopoulou, P. A., Kouzelis, K., Christodoulou, P. N., Papanikolaou, A., & Thomas-Tsagli, E. (1998) · Acta Neuropathologica · doi:10.1007/s004010050848 · Cited by 45
Research works printed but not linked: 1
- Martin-Caballero, J., Flores, J. M., Garcia-Palencia, P. & Serrano, M. Tumor susceptibility of p21Waf1/Cip1-deficient mice. Cancer Res. 61, 6234–6238 (2001). This study demonstrates that deletion of Cdkn1a in mice results in spontaneous tumours but with late onset.
Cited by
Sorted by citations
Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
O'Brien, J., Hayder, H., Zayed, Y., & Peng, C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00402 · Cited by 5,287
Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype
Kumari, R., & Jat, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.645593 · Cited by 1,622
How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression
Aubrey, B. J., Kelly, G. L., Janic, A., Herold, M. J., & Strasser, A. (2018) · Cell Death & Differentiation · doi:10.1038/cdd.2017.169 · Cited by 1,395
Cell cycle regulation: p53-p21-RB signaling
Engeland, K. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-00988-z · Cited by 1,367
Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage.
Karimian, A., Ahmadi, Y., & Yousefi, B. (2016) · DNA Repair · doi:10.1016/j.dnarep.2016.04.008 · Cited by 1,110
Metadata
- Authors
- Abbas, T., & Dutta, A.
- Affiliations
- University of Virginia (US)
- Corresponding author
- Abbas, Tarek
- Dutta, Anindya
- Venue
- Nature Reviews Cancer
- Published
- 2009-05-14
- Volume
- 9
- Issue
- 6
- Pages
- 400-414
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC2722839
- OpenAlex
- W2162262059
- Cited by
- 2,712
- References
- 236
- Citations by year
- 2026: 99 · 2025: 156 · 2024: 161 · 2023: 206 · 2022: 182 · 2021: 205 · 2020: 204 · 2019: 180 · 2018: 191 · 2017: 196 · 2016: 148 · 2015: 160 · 2014: 142 · 2013: 151 · 2012: 122
- FWCI
- 9.54
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (R01CA089406, R01 CA 89406, T32CA009109)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- p21, cyclin-dependent kinase inhibitors, cell cycle arrest, therapeutic target, cell transformation
- MeSH terms
- Animals, Cell Cycle, Humans, Neoplasms, Tumor Suppressor Protein p53, Cyclin-Dependent Kinase Inhibitor p21
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review